Abstracte Clinically, HPV-positive oropharyngeal cancers (OPCs) have been shown to have
a distinct prognosis, compared to HPV-negative tumours, particularly in survival rates and …

Human papillomaviruses (HPV) cause a subset of head and neck cancers (HNSCC). HPV16
predominantly signs responsible for approximately 10% of all HNSCC and over 50% of …

Background Treatment de-intensification, including transoral robotic surgery (TORS), may
outcomes in HPV-positive oropharyngeal squamous cell carcinoma (OPSCC). Early return …

Human papillomavirus (HPV) was proven to play a significant role in cancer development in
the oropharynx. However, its role in the development of laryngeal (LSCC) and …

The prognosis of patients with human papillomavirus (HPV)‑negative head and neck
squamous cell carcinoma (HNSCC) is poorer than those with HPV‑positive HNSCC. The …

In cervical biopsies, for diagnosis of Human Papilloma Virus (HPV) related conditions, the
immunohistochemical staining for p16 has a diagnostic value only if diffusely and strongly …

Tumour infiltrating lymphocytes (TILs) have been described as a biomarker for the host
immune response against the tumour with prognostic properties. The International Immuno …

Epstein‒Barr virus (EBV) infection is a primary oncogenic factor of nasopharyngeal
carcinoma (NPC) that elicits epithelial–mesenchymal transition (EMT). Although diabetic …

Over 70% of oropharyngeal head and neck squamous cell carcinoma (HNSC) cases in the
United States are positive for human papillomavirus (HPV) yet biomarkers for stratifying …

Currently, the role of human papillomavirus (HPV) in carcinogenesis is well known: more
than 90% of HPV-positive oropharyngeal squamous cell carcinomas are caused by HPV …